Denmark · Series B startup

Who invested in Biosyntia

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$14Mraised across 2 rounds since 2015, from 2 sources

$1.9MSeed$12MSeries B
Latest round
Series B, $12MJul 2022
Step-upi
6.3×
Investors
3
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20152016201720182019202020212022
$1.9MSeed$12MSeries B
First round
Seed, $1.9M
May 2015
Biggest round
$12M
Series B · Jul 2022
Between rounds
7.1 years
from the last two

The rounds

  1. Jul 2022
    Series B$12M1 new1 returning

    Source recorded

  2. May 2015
    Seed$1.9M2 new

    From a historical funding record

Founders and team

From Biosyntia's own website: 9 on the team.

  • Martin PlambechChief Executive Officer
  • Daniel WarmingSenior Manager, Finance and Operations
  • Joe PowerSenior Sales & Commercialisation Director
  • Joshua Rey TorresSenior Scientist
  • Joško BobanovićBoard Member
  • Michael NettersheimBoard Member
  • Periklis SotirisSenior Scientist
  • Sara SandeBoard Member
  • Thomas GrotkjærBoard Member

AdvisersDr. Hans-Peter Hohmann Industry Expert

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Novo HoldingsVC firm2rounds
Sofinnova PartnersVC firm1round
Novo Holdings A/SGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Biosyntia

Who invested in Biosyntia?

Biosyntia's investors include Novo Holdings, Sofinnova Partners and Novo Holdings A/S.

How much has Biosyntia raised?

Biosyntia has raised $14M across 2 rounds since 2015.

When did Biosyntia last raise?

Biosyntia's most recent round was a Series B of $12M in Jul 2022.

What was Biosyntia's biggest round?

Its most recent round, $12M in Jul 2022, is also its largest on record.

Who backed Biosyntia first?

Biosyntia's first round on record, in May 2015, was backed by Novo Holdings and Novo Holdings A/S.

What stage is Biosyntia at?

Biosyntia's latest named round is a Series B, in Jul 2022.

Where is Biosyntia based?

Biosyntia is based in Denmark.

Companies like Biosyntia

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.